NHF provides a range of benefits to neonates, infants, and children

There is increasing evidence supporting the use of NHF in neonates, infants, and children. NHF typically improves therapy success and decreases the need for escalation of care when used early and cohesively across the hospital compared to standard oxygen therapy.2


How does NHF therapy work?

There are several mechanisms of action and benefits associated with NHF therapy for neonates, infants, and children.

Nasal High Flow reduces anatomical dead space

Reduces anatomical dead space

Wash-out of the anatomical dead space in the nasopharyngeal cavity is a principal mechanism of action of NHF.3
Nasal High Flow dynamic positive airway pressure

Dynamic positive airway pressure

The delivery of dynamic positive airway pressure associated with NHF has been shown to reduce inspiratory effort and work of breathing compared to standard oxygen therapy.4-6

NHF improves patient comfort

Improves patient comfort

NHF is gentle on the nose, which improves patient comfort, compliance, and tolerance to therapy.7,8

Evidence-based applications for NHF

There is a well-established evidence base that describes how NHF can be used to support the patient pathway through the hospital.
Learn more about the applications of NHF for different patient populations.

Optiflow Junior 2 Nasal interface

Optiflow™ Junior 2 Nasal Interface

The Fisher & Paykel Healthcare Optiflow Junior 2 Nasal Interace is a non-sealing interface specifically designed for the flow requirements and anatomical features of neonatal, infants, and children on NHF therapy.